Cnbc
Cnbc
@cnbc·4.2M subscribers·16.1K videos

Buyable Biotech? | CNBC

Posted

May 27, 2014

Views

840

Likes

2

Engagement

0.24%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

YouTube Description

as posted by the channel

Positive data is made Isis Pharma's stock soar higher, but it's still down big for the year. Is now the time to get in? Jim Cramer gives his prognosis when he talks to its CEO.

» Subscribe to CNBC

About: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.

Connect with CNBC News Online!

Get the latest news

Find CNBC News on Facebook

Follow CNBC News on Twitter

Follow CNBC News on Google+

Follow CNBC News on Instagram

Buyable Biotech? | CNBC

Guests & Subjects Covered

Isis Pharma'sJim CramerCNBC About FromReality TVCNBC News Online GetFind CNBC NewsFacebook Follow CNBC NewsTwitter Follow CNBC News

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.

Buyable Biotech? | CNBC · CNBC Television · Sentinel